Bora Pharmaceuticals Co., LTD. (TPE: 6472)

Bora Pharmaceuticals Co., LTD. Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 17, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	84,532	64,612	31,121	12,446	10,634	5,609
Market Cap Growth	17.18%	107.61%	150.04%	17.05%	89.60%	71.07%
Enterprise Value	98,911	67,752	36,584	13,828	11,299	5,838
Last Close Price	818.00	629.21	311.25	123.77	105.34	57.65
PE Ratio	22.04	21.32	22.36	16.60	18.38	18.39
Forward PE	17.48	21.03	11.57	15.18	21.75	-
PS Ratio	4.96	4.55	2.97	2.54	5.91	3.67
PB Ratio	7.01	5.49	6.05	3.95	4.31	3.39
P/TBV Ratio	12.48	18.52	13.07	4.17	4.32	3.43
P/FCF Ratio	42.99	14.97	17.14	11.60	372.33	-
P/OCF Ratio	31.94	14.00	15.48	10.06	59.81	24.20
EV/Sales Ratio	5.92	4.77	3.49	2.82	6.28	3.82
EV/EBITDA Ratio	20.53	11.82	16.87	11.42	31.90	12.91
EV/EBIT Ratio	24.80	12.91	19.03	13.22	49.98	16.93
EV/FCF Ratio	50.30	15.70	20.15	12.89	395.62	-
Debt / Equity Ratio	1.35	0.42	1.48	0.70	1.17	0.86
Debt / EBITDA Ratio	3.89	0.86	3.44	1.80	7.88	3.05
Debt / FCF Ratio	9.53	1.16	4.18	2.07	100.89	-
Asset Turnover	0.50	0.59	0.70	0.68	0.35	0.54
Inventory Turnover	2.34	3.38	5.19	3.16	1.56	3.54
Quick Ratio	1.35	0.91	0.95	0.96	0.61	1.60
Current Ratio	1.82	1.29	1.17	1.52	1.15	2.24
Return on Equity (ROE)	35.80%	36.34%	33.80%	26.69%	28.09%	20.51%
Return on Assets (ROA)	7.44%	13.72%	7.97%	9.09%	2.72%	7.68%
Return on Capital (ROIC)	10.42%	22.25%	13.27%	12.20%	3.36%	8.71%
Earnings Yield	4.54%	4.69%	4.47%	6.02%	5.44%	5.44%
FCF Yield	2.33%	6.68%	5.83%	8.62%	0.27%	-8.30%
Dividend Yield	1.52%	1.91%	1.98%	1.98%	1.07%	1.50%
Payout Ratio	31.61%	20.43%	17.16%	14.64%	14.39%	29.01%
Buyback Yield / Dilution	-3.82%	-4.93%	-1.40%	-0.86%	-7.55%	-7.29%
Total Shareholder Return	-2.31%	-3.02%	0.57%	1.12%	-6.49%	-5.79%

Source: S&P Capital IQ. Standard template. Financial Sources.